Fadogia agrestis is a Nigerian shrub traditionally used as an aphrodisiac and marketed today primarily as a testosterone booster. The plant has gained popularity in fitness and men’s health circles, but the evidence behind it comes entirely from animal studies. No human clinical trials have been published. Here’s what the research actually shows and what remains unknown.
Traditional Use as an Aphrodisiac
In West Africa, the stem of fadogia agrestis has a long history as a folk remedy for sexual dysfunction. Known locally as “bakin gagai” or “gai gai,” the plant earned the nickname “black aphrodisiac” for its reported ability to enhance male sexual performance. Traditional preparations typically involved boiling or soaking the stems in water to create an extract.
This traditional reputation is what initially drew scientific interest to the plant, and it’s the foundation for nearly all of the modern supplement marketing around fadogia agrestis.
Testosterone and Sexual Function in Rat Studies
The most cited study on fadogia agrestis, published in the Journal of Ethnopharmacology, tested a water-based stem extract on male rats at three doses: 18, 50, and 100 mg per kilogram of body weight. Over five days of dosing, all three groups showed significantly increased blood testosterone levels in what appeared to be a dose-dependent pattern, meaning higher doses produced larger increases.
The behavioral effects tracked with the testosterone changes. Treated rats mounted more frequently, initiated mating faster, and delayed ejaculation longer compared to controls. The researchers concluded that the testosterone increase was likely driving these behavioral shifts and suggested the extract could potentially help with sexual dysfunction caused by low testosterone.
A separate rat study found that fadogia agrestis extract reversed sexual dysfunction caused by paroxetine, a common antidepressant known to impair sexual function. The extract restored nitric oxide signaling and reduced oxidative stress in testicular and penile tissue, performing comparably to sildenafil (the active ingredient in Viagra) on several lab markers. The study authors specifically noted that human clinical trials would need to happen before any real-world recommendations could be made.
What’s Actually in the Plant
Chemical analysis of fadogia agrestis stems has identified alkaloids and saponins as the primary active compounds. Anthraquinones and flavonoids are present in smaller amounts. Researchers have also isolated six unique monoterpene glycosides from the plant, compounds built from sugar molecules attached to a specific type of plant alcohol. These glycosides are derivatives of rhamnose and glucose sugars.
Saponins are the most likely candidates for the testosterone-related effects. Plant saponins can structurally resemble steroid hormones and interact with similar pathways in the body. However, no study has yet isolated which specific compound in fadogia agrestis is responsible for the observed testosterone increase in rats.
The Gap Between Rat Data and Human Use
The biggest limitation with fadogia agrestis is straightforward: every positive finding comes from rodent studies. Rats metabolize compounds differently than humans, and effects observed in animal models frequently fail to translate when tested in people. The testosterone increases seen in rats over five days of dosing tell us the plant contains biologically active compounds, but they don’t tell us whether those same compounds raise testosterone in humans, at what dose, or for how long.
Supplement brands commonly sell fadogia agrestis in capsules of 400 to 600 mg per dose. These numbers are loosely extrapolated from the rat studies using standard body-weight conversion formulas, but without human pharmacokinetic data, no one can say whether these doses are effective, insufficient, or excessive. The rat studies used a simple water extract of the stem, which may differ significantly from the concentrated or standardized extracts found in commercial supplements.
Athletic Performance Claims
You’ll find fadogia agrestis marketed for lean muscle gain, strength, and athletic performance. The logic is indirect: if the plant raises testosterone, and testosterone supports muscle growth, then the plant should help build muscle. This chain of reasoning has two weak links. First, the testosterone increase hasn’t been confirmed in humans. Second, even if it does raise testosterone, the magnitude matters. Small, transient bumps in testosterone from supplements rarely produce measurable changes in muscle mass or strength. The anabolic threshold for muscle growth typically requires sustained, substantial elevations.
No study has measured muscle mass, strength, or exercise performance in any animal or human taking fadogia agrestis.
Safety Concerns
The safety profile of fadogia agrestis is poorly characterized. The same rat study that demonstrated aphrodisiac effects used doses up to 100 mg/kg, and while sexual behavior improved, longer-term toxicity was not assessed in that particular experiment. Some animal research on similar plant extracts has flagged potential concerns with kidney and liver stress markers, including elevated creatinine and changes in liver enzymes, though these findings haven’t been specifically confirmed for fadogia agrestis at typical supplement doses.
The plant contains alkaloids and anthraquinones, both compound classes that can be toxic at high doses or with prolonged use. Without human safety data, the risks of taking fadogia agrestis over weeks or months are genuinely unknown. People with existing kidney or liver conditions face particular uncertainty, since the body’s ability to clear these compounds depends on those organs functioning normally.
Cycling the supplement (taking breaks between periods of use) is commonly recommended in fitness communities, but this practice is based on general caution rather than any specific evidence about fadogia agrestis accumulation or toxicity timelines.
The Bottom Line on Evidence
Fadogia agrestis contains biologically active compounds that raise testosterone and improve sexual function in male rats. That’s a genuinely interesting finding, and it aligns with the plant’s long history of traditional use in West Africa. But “interesting in rats” is an early stage of evidence, not a finished one. Many promising animal findings have failed in human testing, and some have turned out to carry unexpected risks.
If you’re considering fadogia agrestis for testosterone support or sexual health, you’re essentially self-experimenting with a compound that lacks human dosing data, human efficacy data, and human safety data. The popularity of this supplement has outpaced the science behind it considerably.